PHARMACEUTICAL DRUG DEVELOPMENT PROCESS: Role of Dissolution Testing
This Professional Development Course Series on the role of Dissolution Testing in pharmaceutical drug development provides a comprehensive mass of critical information to the R&D (formulation and analytical), QC/QA, Regulatory Affairs and PK professionals concerning the intricacies associated with effective dissolution testing, from basics to advanced applications including correlating dissolution and bioavailability as well as biowaivers and clinical applications of IVIVC.
This Professional Advancement Course Series comprises four (4) short focused intensive courses structured as building blocks – from basics all the way to biowaivers and clinical applications. Each course is profuse with numerous examples and case studies as well as the instructor’s vast experience(s) which provide a practical perspective of dissolution testing at various stages in drug development process to the participants. It is anticipated that the judicious combination of theoretical details and practical considerations employed by the instructor(s) will provide a consolidated and holistic understanding of the role of dissolution testing in pharmaceutical drug development process.
Course I [22-23 June, 2015]
PHARMACEUTICAL DISSOLUTION TESTING:
Fundamentals and Advanced Applications
COURSE II [24-25 August, 2015]
BIOEFFICACY CENTERED DISSOLUTION
METHOD DEVELOPMENT: Applications and Analyses
COURSE III [19-20 October, 2015]
DISSOLUTION AND BIOAVAILABILITY:
Fundamentals and Applications of IVIVC
Automation in Dissolution Testing & Dissolution studies for novel drug delivery systems
Date : 21-22 March, 2016.
Course V [4-5 July, 2016]
QbD in Dissolution Method Development : QTTP, Critical Method Atributes, Discriminatory Method.DOE�s, Method Finalization
COURSE VI [24th & 25th Jan 2018]
IVIVC, BIOWAIVERS AND CLINICAL
APPLICATIONS OF IVIVC